# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-029865
Filing Date
2024-03-01
Accepted
2024-03-01 14:12:25
Documents
4
Period of Report
2024-03-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | tm247743d2_6k.htm | 6-K | 17147
2 | GRAPHIC | tm247743d2_6kimg01.jpg | GRAPHIC | 541460
3 | GRAPHIC | tm247743d2_6kimg02.jpg | GRAPHIC | 373586
4 | GRAPHIC | tm247743d2_6kimg03.jpg | GRAPHIC | 406023
| Complete submission text file | 0001104659-24-029865.txt |  | 1838180

Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 24708852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)